MAPK15 Antibody (Center) Blocking peptide

Catalog Number: ABT-BP7554C
Article Name: MAPK15 Antibody (Center) Blocking peptide
Biozol Catalog Number: ABT-BP7554C
Supplier Catalog Number: BP7554c
Alternative Catalog Number: ABT-BP7554C-500UG
Manufacturer: Abcepta
Category: Proteine/Peptide
Alternative Names: Mitogen-activated protein kinase 15, MAP kinase 15, MAPK 15, Extracellular signal-regulated kinase 7, ERK-7, Extracellular signal-regulated kinase 8, ERK-8, MAPK15, ERK7, ERK8
The ERKs are a subfamily of the MAPKs that have been implicated in cell growth and differentiation. Extracellular signal-regulated kinase 8 (Erk8) is a large MAP kinase whose activity is controlled by serum and the c-Src non-receptor tyrosine kinase. ERK8 down-regulates transactivation of the glucocorticoid receptor through Hic-5 and can negatively regulate transcriptional co-activation of androgen receptor and GRalpha by Hic-5 in a kinase-independent manner, suggesting a broader role for ERK8 in the regulation of nuclear receptors beyond estrogen receptor alpha. Erk8 is a novel effector of RET/PTC3 and, therefore, RET biological functions.
NCBI: 225689
UniProt: Q8TD08
Form: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Target: The synthetic peptide sequence used to generate the antibody AP7554c was selected from the Center region of human ERK8. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.